title: Infliximab in the treatment of rheumatoid arthritis.
abstract: Infliximab was the first monoclonal antibody to human necrosis factor alpha (TNFalpha) developed for treating rheumatoid arthritis (RA). This chimeric antibody binds with high affinity to both soluble and trans-membrane TNF and is able to reduce synovial inflammation, bone resorption and cartilage degradation. The efficacy of infliximab has been observed in active RA despite treatment with multiple disease modifying anti-rheumatic drugs (DMARDs), and in early disease with no prior treatment by methotrexate (MTX). Infliximab has been shown to reduce joint inflammation and to slow radiographic progression, in both clinical and non-clinical responders. Recent data suggest that using infliximab early in RA treatment increases the percentage of clinical remission and allows infliximab discontinuation. The recommended dosage of 3 mg/kg could be increased up to 10 mg/kg with partial efficacy of the dose escalation. Antibodies to infliximab have been observed in 7% to 61% of patients and are associated with a low trough level of infliximab and secondary response failure. Their occurrence could be prevented by co-medication with MTX. The combination of DMARDs other than MTX with infliximab was found to be safe and efficacious. Infections, principally tuberculosis, are increased in treated patients, and the risk is greater at higher dose. Even if the treatment is generally safe and well tolerated, patients treated with infliximab should be closely monitored.
authors.affiliation: Service de Rhumatologie, CHU de Rennes, Hôpital Sud, France. aleth.perdriger@chu-rennes.fr
authors.forename: A
authors.initials: A
authors.lastname: Perdriger
references.citation: Medicine (Baltimore). 2007 Jul;86(4):242-251
references.pmid: 17632266
references.citation: N Engl J Med. 2003 Feb 13;348(7):601-8
references.pmid: 12584368
references.citation: JAMA. 2006 May 17;295(19):2275-85
references.pmid: 16705109
references.citation: Drugs. 2008;68(5):591-606
references.pmid: 18370440
references.citation: N Engl J Med. 2000 Nov 30;343(22):1594-602
references.pmid: 11096166
references.citation: J Infect Dis. 2008 Dec 15;198(12):1842-50
references.pmid: 18954258
references.citation: Semin Arthritis Rheum. 2005 Jun;34(6):819-36
references.pmid: 15942917
references.citation: Clin Pharmacokinet. 2007;46(8):645-60
references.pmid: 17655372
references.citation: Rheum Dis Clin North Am. 2004 May;30(2):329-47, vii
references.pmid: 15172044
references.citation: Clin Exp Rheumatol. 2008 Sep-Oct;26(5):834-40
references.pmid: 19032816
references.citation: Clin Infect Dis. 2005 Aug 1;41 Suppl 3:S199-203
references.pmid: 15983900
references.citation: Arthritis Rheum. 2007 Jun 15;57(5):756-61
references.pmid: 17530674
references.citation: Ann Rheum Dis. 2009 Jul;68(7):1153-8
references.pmid: 18930988
references.citation: Clin Exp Rheumatol. 2006 Nov-Dec;24(6 Suppl 43):S-77-82
references.pmid: 17083767
references.citation: J Rheumatol. 2009 Mar;36(3):635-41
references.pmid: 19132789
references.citation: Arthritis Rheum. 2004 Dec;50(12):4072-3
references.pmid: 15593202
references.citation: J Clin Immunol. 2008 Sep;28(5):445-55
references.pmid: 18587633
references.citation: Clin Ther. 2008 Nov;30(11):1939-55
references.pmid: 19108784
references.citation: Arthritis Rheum. 2007 Jul;56(7):2129-34
references.pmid: 17599726
references.citation: Arthritis Rheum. 2007 Dec;56(12):3919-27
references.pmid: 18050189
references.citation: Arthritis Res Ther. 2006;8(4):R112
references.pmid: 16978395
references.citation: Ann Rheum Dis. 2009 Jan;68(1):33-9
references.pmid: 18230627
references.citation: Arthritis Rheum. 2006 Apr;54(4):1075-86
references.pmid: 16572442
references.citation: Rheumatology (Oxford). 2007 Mar;46(3):529-32
references.pmid: 17012439
references.citation: Clin Gastroenterol Hepatol. 2006 Oct;4(10):1248-54
references.pmid: 16931170
references.citation: Muscle Nerve. 2008 Mar;37(3):281-92
references.pmid: 18041052
references.citation: Arthritis Rheum. 2004 Apr;50(4):1051-65
references.pmid: 15077287
references.citation: Arthritis Rheum. 1998 Sep;41(9):1552-63
references.pmid: 9751087
references.citation: Arthritis Rheum. 2005 Apr;52(4):1020-30
references.pmid: 15818697
references.citation: Arthritis Rheum. 2004 Apr 15;51(2):228-32
references.pmid: 15077264
references.citation: Pharmacol Ther. 2008 Feb;117(2):244-79
references.pmid: 18155297
references.citation: Arthritis Res Ther. 2007;9 Suppl 1:S1
references.pmid: 17634140
references.citation: Ann Rheum Dis. 2009 Nov;68(11):1739-45
references.pmid: 19019895
references.citation: Rheumatology (Oxford). 2002 Jun;41(6):631-7
references.pmid: 12048288
references.citation: Arthritis Rheum. 2002 Sep;46(9):2287-93
references.pmid: 12355475
references.citation: Clin Exp Rheumatol. 2008 Jan-Feb;26(1):18-23
references.pmid: 18328142
references.citation: Ann Rheum Dis. 2007 Nov;66 Suppl 3:iii2-22
references.pmid: 17934088
references.citation: Mod Rheumatol. 2008;18(5):460-4
references.pmid: 18535759
references.citation: Arthritis Rheum. 2006 Mar;54(3):692-701
references.pmid: 16508929
references.citation: Ann Rheum Dis. 2008 Mar;67(3):353-7
references.pmid: 17644538
references.citation: J Rheumatol. 2004 Aug;31(8):1538-45
references.pmid: 15290732
references.citation: Rheumatology (Oxford). 2007 Jan;46(1):146-9
references.pmid: 16782732
references.citation: Arthritis Rheum. 2005 Jan;52(1):61-72
references.pmid: 15641091
references.citation: Ann Rheum Dis. 2008 May;67(5):620-4
references.pmid: 17720725
references.citation: Arthritis Res Ther. 2006;8(4):R131
references.pmid: 16869978
references.citation: Drug Discov Today. 2007 Jul;12(13-14):548-52
references.pmid: 17631249
references.citation: Clin Exp Rheumatol. 2006 Jan-Feb;24(1):38-44
references.pmid: 16539817
references.citation: Arthritis Rheum. 2002 Dec;46(12):3151-8
references.pmid: 12483718
references.citation: Arthritis Rheum. 2005 Nov;52(11):3403-12
references.pmid: 16255017
references.citation: Cytokine Growth Factor Rev. 2004 Oct;15(5):353-66
references.pmid: 15450251
references.citation: Am J Med. 2007 Dec;120(12):e21; author reply e23
references.pmid: 18060907
references.citation: Autoimmun Rev. 2008 Dec;8(2):147-52
references.pmid: 18706526
references.citation: Ann Rheum Dis. 2007 Sep;66(9):1233-8
references.pmid: 17392352
references.citation: Arthritis Rheum. 2006 Mar;54(3):702-10
references.pmid: 16508926
references.citation: N Engl J Med. 2001 Mar 22;344(12):907-16
references.pmid: 11259725
references.citation: Arthritis Res Ther. 2007;9(1):202
references.pmid: 17306038
references.citation: Arthritis Rheum. 2004 Jun;50(6):1740-51
references.pmid: 15188349
references.citation: J Rheumatol. 2006 May;33(5):865-9
references.pmid: 16652418
references.citation: J Dtsch Dermatol Ges. 2009 Mar;7(3):191-4
references.pmid: 19192165
references.citation: Arthritis Rheum. 2008 Nov;58(11):3330-9
references.pmid: 18975323
references.citation: J Exp Med. 2004 Aug 2;200(3):277-85
references.pmid: 15280421
references.citation: Ann Rheum Dis. 2009 Jun;68(6):823-7
references.pmid: 18593759
references.citation: Arthritis Rheum. 2006 Jun;54(6):1786-94
references.pmid: 16736520
references.citation: Rheumatology (Oxford). 2007 Jul;46(7):1153-6
references.pmid: 17478470
references.citation: N Engl J Med. 2001 Oct 11;345(15):1098-104
references.pmid: 11596589
references.citation: Br J Dermatol. 2008 Sep;159(3):527-36
references.pmid: 18627374
references.citation: Ann Rheum Dis. 2007 Nov;66 Suppl 3:iii45-8
references.pmid: 17934095
references.citation: Best Pract Res Clin Rheumatol. 2006 Oct;20(5):897-913
references.pmid: 16980213
references.citation: Arthritis Rheum. 2004 Nov;50(11):3432-43
references.pmid: 15529377
references.citation: Arthritis Res Ther. 2006;8(4):R114
references.pmid: 16859506
references.citation: Congest Heart Fail. 2002 Sep-Oct;8(5):275-9
references.pmid: 12368591
references.citation: Arthritis Rheum. 2007 Mar;56(3):710-3
references.pmid: 17328040
references.citation: Blood. 2006 Jul 1;108(1):253-61
references.pmid: 16537805
references.citation: Manag Care Interface. 2005 Apr;18(4):21-7
references.pmid: 15889759
references.citation: Lancet Infect Dis. 2003 Mar;3(3):148-55
references.pmid: 12614731
references.citation: Arthritis Rheum. 2006 Jan;54(1):47-53
references.pmid: 16385521
references.citation: Lancet. 1999 Dec 4;354(9194):1932-9
references.pmid: 10622295
references.citation: Arthritis Rheum. 2005 Nov;52(11):3381-90
references.pmid: 16258899
references.citation: Rheumatology (Oxford). 2003 May;42(5):617-21
references.pmid: 12709536
references.citation: Nat Clin Pract Rheumatol. 2006 Nov;2(11):602-10
references.pmid: 17075599
references.citation: Arthritis Rheum. 2007 Sep;56(9):2886-95
references.pmid: 17729297
references.citation: Drugs. 2000 Jun;59(6):1341-59
references.pmid: 10882166
references.citation: Joint Bone Spine. 2007 Jan;74(1):56-9
references.pmid: 17182267
references.citation: Expert Opin Pharmacother. 2007 Sep;8(13):2089-107
references.pmid: 17714062
references.citation: Rheum Dis Clin North Am. 2004 May;30(2):237-55, v
references.pmid: 15172038
references.citation: Annu Rev Immunol. 1996;14:397-440
references.pmid: 8717520
references.citation: Arthritis Rheum. 2005 Jan;52(1):27-35
references.pmid: 15641102
references.citation: Arthritis Rheum. 2001 Sep;44(9):1977-83
references.pmid: 11592357
references.citation: Gut. 2007 Sep;56(9):1226-31
references.pmid: 17229796